1. Home
  2. ARBB vs BRTX Comparison

ARBB vs BRTX Comparison

Compare ARBB & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARB IOT Group Limited

ARBB

ARB IOT Group Limited

HOLD

Current Price

$6.76

Market Cap

10.2M

Sector

Technology

ML Signal

HOLD

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$1.09

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARBB
BRTX
Founded
1997
1997
Country
Singapore
United States
Employees
N/A
N/A
Industry
EDP Services
Managed Health Care
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2M
9.7M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
ARBB
BRTX
Price
$6.76
$1.09
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
48.3K
80.7K
Earning Date
11-03-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$46,842,655.00
$383,400.00
Revenue This Year
N/A
$112.14
Revenue Next Year
$24.79
$139.81
P/E Ratio
N/A
N/A
Revenue Growth
239.12
1.70
52 Week Low
$3.92
$0.98
52 Week High
$18.60
$2.55

Technical Indicators

Market Signals
Indicator
ARBB
BRTX
Relative Strength Index (RSI) 55.27 42.29
Support Level $5.60 $0.98
Resistance Level $7.15 $1.11
Average True Range (ATR) 0.55 0.13
MACD 0.13 -0.00
Stochastic Oscillator 64.12 36.07

Price Performance

Historical Comparison
ARBB
BRTX

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is a provider of complete solutions to the clients for the integration of Internet of Things (IoT) systems and devices from designing to project deployment. The company offers a wide range of IoT systems as well as provides customers with a substantial range of services such as system integration and system support services. It delivers solutions like designing, installation, testing and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company operates in two reportable segments: (i) the provision of hardware and software of IoT solutions and (ii) Investment holding and others. The majority of revenue is generated from the IoT solutions segment.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: